Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611, Ricky241025, HVE Capital Research, BioManRandy
Search This Board: 
Last Post: 8/19/2017 11:58:55 PM - Followers: 124 - Board type: Free - Posts Today: 0



About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.


Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values


BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.


BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.


BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
    Sector: Healthcare
    Industry: Specialized Health Services
    Full Time Employees: 4
    Public Company: SEC Reporting and fully audited
    Symbol: BICX
    Exchange: OTCBB
    Outstanding: 117,800,000
    Authorized: 200,000,000
    CUSIP: 35804J102
    NAICS Code: 623220
    SIC Number: 8093
    Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
    CIK: 0001443863
    EIN: 26-1972677
    Year End: December 31
    State of incorporation: Nevada
    Products: Alcohol rehabilitation, exclusive naltrexone implant technology
    Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
    Investors: 858-381-4677
Watch Jeremy Miller on Fox News!

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>

<iframe width="560" height="315" src="" frameborder="0" allowfullscreen></iframe>


BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673) 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#9778   Pretty excited to potentially have the only naltrexone RBC- 08/19/17 11:58:54 PM
#9777   Don't let the door hit you Skies_bluer77 08/18/17 08:43:56 PM
#9776   So the original responses that were carefully worded Thirdeyeblind 08/18/17 12:55:25 PM
#9775   I got my response from Biocorrx about the Kizersosae 08/18/17 12:34:26 PM
#9774   You are correct. Additionally, the IRS has very Thirdeyeblind 08/18/17 12:04:23 PM
#9773   Fido you hit the nail on the head Kizersosae 08/18/17 12:01:08 PM
#9772   We'll have an injection for that soon. :) Fido 08/18/17 10:25:29 AM
#9771   Hopefully one last thought on Brady's pay. As stanggt 08/18/17 10:20:09 AM
#9770   My wife would have a cow. It took stanggt 08/18/17 10:18:18 AM
#9769   YES, MORE TWINKIES!!! Go BICX!! Fido 08/18/17 09:50:56 AM
#9768   Guys I was thinking... when BICX gets real Kizersosae 08/18/17 09:06:31 AM
#9767   Agree, which is why I stated that it Fido 08/18/17 08:44:06 AM
#9766   As far as Aetna Website... The dates on Kizersosae 08/17/17 09:03:17 PM
#9765   I'm honestly not convinced though because the link SanFranPatsFan 08/17/17 08:36:52 PM
#9764   Here is the response I got from Brady SanFranPatsFan 08/17/17 08:21:53 PM
#9763   Yes, companies prefer to pay consultant fees rather SanFranPatsFan 08/17/17 08:20:02 PM
#9762   Agree. I have seen companies have this a Jon Boyz 08/17/17 07:18:29 PM
#9761   If you pay a consultant they are responsible Fido 08/17/17 06:28:42 PM
#9760   Haha great minds think a like... this was Kizersosae 08/17/17 04:33:04 PM
#9759   Honestly, her response just validates 3rd's contention, and mkjoke 08/17/17 04:26:21 PM
#9758   I dont know what you want to hear Kizersosae 08/17/17 04:23:33 PM
#9757   Maybe the impersonator but not me. We don't Thirdeyeblind 08/17/17 03:36:50 PM
#9756   However, the latest 10-q shows salary payments as Thirdeyeblind 08/17/17 03:33:30 PM
#9755   Well that's what I was told by a moderator Kizersosae 08/17/17 03:32:44 PM
#9754   I didnt hit a report button. I didnt Thirdeyeblind 08/17/17 03:31:45 PM
#9753   I write long researched responses to all of Kizersosae 08/17/17 03:04:36 PM
#9752   I copied and pasted your question, here is Kizersosae 08/17/17 02:40:54 PM
#9751   Haha get him KIZ! It's gonna be a Followmylead 08/17/17 01:45:03 PM
#9749   Ask her this simple question so she can't Thirdeyeblind 08/17/17 01:08:52 PM
#9748   Email all your concerns, call them out and Kizersosae 08/17/17 12:59:40 PM
#9747   Do you understand her reply? She is saying Thirdeyeblind 08/17/17 12:55:18 PM
#9744   I want to believe these people. I did Thirdeyeblind 08/17/17 12:05:57 PM
#9742   Did you ever email them with concerns? I Kizersosae 08/17/17 11:58:58 AM
#9741   If i wanted cheap shares I'd just lend Thirdeyeblind 08/17/17 11:54:44 AM
#9739   If that's the case then he must have Thirdeyeblind 08/17/17 11:50:38 AM
#9738   He can't keep himself away. He's doing everything Jon Boyz 08/17/17 11:50:13 AM
#9736   The FDA charges approx 2 million dollars Thirdeyeblind 08/17/17 11:28:51 AM
#9735   There's the Third Eye that we all know captainhook002 08/17/17 11:27:12 AM
#9734   @Thirdeyeblind..I have talked, emailed Brady MORE than you Drum 08/17/17 11:23:44 AM
#9732   Brady's email response to my today a.m. question Drum 08/17/17 11:00:42 AM
#9731   When Brady sells we will sell. Or $3 Followmylead 08/17/17 10:53:17 AM
#9730   AGREE......"Followmylead" Drum 08/17/17 10:51:13 AM
#9729   I think people actually liked the CC. Caught Followmylead 08/17/17 10:47:58 AM
#9728   BICX WILL GET GOV. Grants!!! With declaration of Drum 08/17/17 10:44:32 AM
#9727   Yes, we are all aware that he was Fido 08/17/17 10:12:40 AM
#9726   Why do you think he was at WH? Jon Boyz 08/17/17 10:11:11 AM
#9725   Stock action much better today. The fact that stanggt 08/17/17 10:10:40 AM
#9724   That's why your comment on "govt agencies" is Fido 08/17/17 10:08:50 AM
#9723   And another thing, if insurance doesn't cover it, Pip611 08/17/17 09:30:27 AM
#9722   The key from the latest update was "gov't Pip611 08/17/17 09:28:53 AM